Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Cerebral Small Vessel Disease | Research

High homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study

Authors: Shisheng Ye, Kaiyan Feng, Yizhong Li, Sanxin Liu, Qiaoling Wu, Jinwen Feng, Xiaorong Liao, Chunmei Jiang, Bo Liang, Li Yuan, Hai Chen, Jinbo Huang, Zhi Yang, Zhengqi Lu, Hao Li

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background and objective

The pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) remain unclear. Homocysteine may reduce the compliance of intracranial arteries and damage the endothelial function of the blood-brain barrier (BBB), which may be the underlying mechanism of iNPH. The overlap cases between deep perforating arteriopathy (DPA) and iNPH were not rare for the shared risk factors. We aimed to investigate the relationship between serum homocysteine and iNPH in DPA.

Methods

A total of 41 DPA patients with iNPH and 49 DPA patients without iNPH were included. Demographic characteristics, vascular risk factors, laboratory results, and neuroimaging data were collected. Multivariable logistic regression analysis was performed to investigate the relationship between serum homocysteine and iNPH in DPA patients.

Results

Patients with iNPH had significantly higher homocysteine levels than those without iNPH (median, 16.34 mmol/L versus 14.28 mmol/L; P = 0.002). There was no significant difference in CSVD burden scores between patients with iNPH and patients without iNPH. Univariate logistic regression analysis demonstrated that patients with homocysteine levels in the Tertile3 were more likely to have iNPH than those in the Tertile1 (OR, 4.929; 95% CI, 1.612–15.071; P = 0.005). The association remained significant after multivariable adjustment for potential confounders, including age, male, hypertension, diabetes mellitus, atherosclerotic cardiovascular disease (ASCVD) or hypercholesterolemia, and eGFR level.

Conclusion

Our study indicated that high serum homocysteine levels were independently associated with iNPH in DPA. However, further research is needed to determine the predictive value of homocysteine and to confirm the underlying mechanism between homocysteine and iNPH.
Literature
1.
go back to reference Hakim S, Adams R. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2: 307–327CrossRefPubMed Hakim S, Adams R. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2: 307–327CrossRefPubMed
2.
go back to reference Relkin N, Marmarou A, Klinge P et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurg. 2005;57: S4-16; discussion ii-vCrossRefPubMed Relkin N, Marmarou A, Klinge P et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurg. 2005;57: S4-16; discussion ii-vCrossRefPubMed
3.
go back to reference Lilja-Lund O, Maripuu M, Kockum K et al. Longitudinal neuropsychological trajectories in idiopathic normal pressure hydrocephalus: a population–based study. BMC Geriatr. 2023;23(1):29CrossRefPubMedPubMedCentral Lilja-Lund O, Maripuu M, Kockum K et al. Longitudinal neuropsychological trajectories in idiopathic normal pressure hydrocephalus: a population–based study. BMC Geriatr. 2023;23(1):29CrossRefPubMedPubMedCentral
4.
go back to reference Greitz D. Radiological assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev. 2004;27: 145–165; discussion 66–67CrossRefPubMed Greitz D. Radiological assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev. 2004;27: 145–165; discussion 66–67CrossRefPubMed
5.
go back to reference Wang Z, Zhang Y, Hu F et al. Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus. CNS Neurosci Ther. 2020;26: 1230–1240CrossRef Wang Z, Zhang Y, Hu F et al. Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus. CNS Neurosci Ther. 2020;26: 1230–1240CrossRef
6.
go back to reference Yamada S, Ishikawa M, Nozaki K. Exploring mechanisms of ventricular enlargement in idiopathic normal pressure hydrocephalus: a role of cerebrospinal fluid dynamics and motile cilia. Fluids and Barriers CNS. 2021;18: 20CrossRefPubMedPubMedCentral Yamada S, Ishikawa M, Nozaki K. Exploring mechanisms of ventricular enlargement in idiopathic normal pressure hydrocephalus: a role of cerebrospinal fluid dynamics and motile cilia. Fluids and Barriers CNS. 2021;18: 20CrossRefPubMedPubMedCentral
7.
go back to reference Mudd S, Finkelstein J, Refsum H et al. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol. 2000;20: 1704–1706CrossRefPubMed Mudd S, Finkelstein J, Refsum H et al. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol. 2000;20: 1704–1706CrossRefPubMed
8.
go back to reference Cao Y, Su N, Zhang D et al. Correlation between total homocysteine and cerebral small vessel disease: a mendelian randomization study. Eur J Neurol. 2021;28: 1931–1938CrossRefPubMed Cao Y, Su N, Zhang D et al. Correlation between total homocysteine and cerebral small vessel disease: a mendelian randomization study. Eur J Neurol. 2021;28: 1931–1938CrossRefPubMed
9.
go back to reference Zhao M, Wang X, He M et al. Homocysteine and Stroke Risk: modifying effect of Methylenetetrahydrofolate Reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48: 1183–1190CrossRefPubMed Zhao M, Wang X, He M et al. Homocysteine and Stroke Risk: modifying effect of Methylenetetrahydrofolate Reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48: 1183–1190CrossRefPubMed
10.
go back to reference Wang Q, Zhao J, Chang H. Homocysteine and Folic Acid: risk factors for Alzheimer’s Disease-An updated Meta-analysis. Front Aging Neurosci. 2021;13: 665114CrossRefPubMedPubMedCentral Wang Q, Zhao J, Chang H. Homocysteine and Folic Acid: risk factors for Alzheimer’s Disease-An updated Meta-analysis. Front Aging Neurosci. 2021;13: 665114CrossRefPubMedPubMedCentral
11.
go back to reference Kim B, Seo M, Huh J et al. Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clin Exp Hypertens (New York, NY: 1993). 2011;33: 411–417 Kim B, Seo M, Huh J et al. Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clin Exp Hypertens (New York, NY: 1993). 2011;33: 411–417
12.
go back to reference Škovierová H, Vidomanová E, Mahmood S et al. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int J Mol Sci. 2016;17 Škovierová H, Vidomanová E, Mahmood S et al. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int J Mol Sci. 2016;17
13.
14.
go back to reference Beard R, Reynolds J, Bearden S. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood. 2011;118: 2007–2014CrossRefPubMedPubMedCentral Beard R, Reynolds J, Bearden S. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood. 2011;118: 2007–2014CrossRefPubMedPubMedCentral
15.
16.
go back to reference Sosvorová L, Bešťák J, Bičíková M et al. Determination of homocysteine in cerebrospinal fluid as an indicator for surgery treatment in patients with hydrocefalus. Physiol Res. 2014;63: 521–527CrossRefPubMed Sosvorová L, Bešťák J, Bičíková M et al. Determination of homocysteine in cerebrospinal fluid as an indicator for surgery treatment in patients with hydrocefalus. Physiol Res. 2014;63: 521–527CrossRefPubMed
17.
go back to reference He R, Zhang H, Kang L et al. Analysis of 70 patients with hydrocephalus due to cobalamin C deficiency. Neurology. 2020;95: e3129-e3137CrossRefPubMed He R, Zhang H, Kang L et al. Analysis of 70 patients with hydrocephalus due to cobalamin C deficiency. Neurology. 2020;95: e3129-e3137CrossRefPubMed
18.
go back to reference Schreiber S, Wilisch-Neumann A, Schreiber F et al. Invited review: the spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies. Neuropathol Appl Neurobiol. 2020;46: 219–239CrossRefPubMed Schreiber S, Wilisch-Neumann A, Schreiber F et al. Invited review: the spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies. Neuropathol Appl Neurobiol. 2020;46: 219–239CrossRefPubMed
19.
go back to reference Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9: 689–701CrossRefPubMed Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9: 689–701CrossRefPubMed
20.
go back to reference Israelsson H, Carlberg B, Wikkelsö C et al. Vascular risk factors in INPH: a prospective case-control study (the INPH-CRasH study). Neurology. 2017;88: 577–585CrossRefPubMedPubMedCentral Israelsson H, Carlberg B, Wikkelsö C et al. Vascular risk factors in INPH: a prospective case-control study (the INPH-CRasH study). Neurology. 2017;88: 577–585CrossRefPubMedPubMedCentral
21.
go back to reference Jaraj D, Agerskov S, Rabiei K et al. Vascular factors in suspected normal pressure hydrocephalus: a population-based study. Neurology. 2016;86: 592–599CrossRefPubMedPubMedCentral Jaraj D, Agerskov S, Rabiei K et al. Vascular factors in suspected normal pressure hydrocephalus: a population-based study. Neurology. 2016;86: 592–599CrossRefPubMedPubMedCentral
22.
go back to reference Wardlaw J, Smith E, Biessels G et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12: 822–838CrossRefPubMedPubMedCentral Wardlaw J, Smith E, Biessels G et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12: 822–838CrossRefPubMedPubMedCentral
23.
go back to reference Chen X, Wei L, Wang J et al. Decreased visible deep medullary veins is a novel imaging marker for cerebral small vessel disease. Neurol Sci. 2020;41: 1497–1506CrossRefPubMed Chen X, Wei L, Wang J et al. Decreased visible deep medullary veins is a novel imaging marker for cerebral small vessel disease. Neurol Sci. 2020;41: 1497–1506CrossRefPubMed
24.
25.
go back to reference Grundy S, Stone N, Bailey A et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circ. (2019)2018;139: e1082-e1143 Grundy S, Stone N, Bailey A et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circ. (2019)2018;139: e1082-e1143
26.
go back to reference Teo BW, Xu H, Wang D et al. GFR estimating equations in a multiethnic asian population. Am J Kidney Dis. 2011;58: 56–63CrossRefPubMed Teo BW, Xu H, Wang D et al. GFR estimating equations in a multiethnic asian population. Am J Kidney Dis. 2011;58: 56–63CrossRefPubMed
27.
go back to reference Faverzani J, Hammerschmidt T, Sitta A. Oxidative stress in Homocystinuria due to Cystathionine ß-Synthase Deficiency: findings in patients and in animal models. Cell Mol Neurobiol. 2017;37: 1477–1485CrossRefPubMed Faverzani J, Hammerschmidt T, Sitta A. Oxidative stress in Homocystinuria due to Cystathionine ß-Synthase Deficiency: findings in patients and in animal models. Cell Mol Neurobiol. 2017;37: 1477–1485CrossRefPubMed
28.
go back to reference Barroso M, Kao D, Blom H et al. S-adenosylhomocysteine induces inflammation through NFkB: a possible role for EZH2 in endothelial cell activation. Biochimica et biophysica acta. 2016;1862: 82–92CrossRefPubMed Barroso M, Kao D, Blom H et al. S-adenosylhomocysteine induces inflammation through NFkB: a possible role for EZH2 in endothelial cell activation. Biochimica et biophysica acta. 2016;1862: 82–92CrossRefPubMed
29.
go back to reference Eide P, Hansson H. Blood-brain barrier leakage of blood proteins in idiopathic normal pressure hydrocephalus. Brain Res. 2020;1727: 146547CrossRefPubMed Eide P, Hansson H. Blood-brain barrier leakage of blood proteins in idiopathic normal pressure hydrocephalus. Brain Res. 2020;1727: 146547CrossRefPubMed
30.
go back to reference Hassan A, Hunt B, O’Sullivan M et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain: a journal of neurology. 2004;127: 212–219CrossRefPubMed Hassan A, Hunt B, O’Sullivan M et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain: a journal of neurology. 2004;127: 212–219CrossRefPubMed
31.
go back to reference Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131: 362–369CrossRefPubMed Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131: 362–369CrossRefPubMed
32.
go back to reference Nam K, Kwon H, Jeong H. Serum homocysteine level is related to cerebral small vessel disease in a healthy population. Neurology. 2019;92: e317-e325CrossRefPubMed Nam K, Kwon H, Jeong H. Serum homocysteine level is related to cerebral small vessel disease in a healthy population. Neurology. 2019;92: e317-e325CrossRefPubMed
33.
go back to reference Tseng Y, Chang Y, Liu J. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. J Neurol Sci. 2009;284: 36–39CrossRefPubMed Tseng Y, Chang Y, Liu J. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. J Neurol Sci. 2009;284: 36–39CrossRefPubMed
34.
go back to reference Smith A, Refsum H. Homocysteine, B Vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36: 211–239CrossRefPubMed Smith A, Refsum H. Homocysteine, B Vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36: 211–239CrossRefPubMed
35.
go back to reference Román G, Verma A, Zhang Y. Idiopathic normal-pressure hydrocephalus and obstructive sleep apnea are frequently associated: a prospective cohort study. J Neurol Sci. 2018;395: 164–168CrossRefPubMed Román G, Verma A, Zhang Y. Idiopathic normal-pressure hydrocephalus and obstructive sleep apnea are frequently associated: a prospective cohort study. J Neurol Sci. 2018;395: 164–168CrossRefPubMed
Metadata
Title
High homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study
Authors
Shisheng Ye
Kaiyan Feng
Yizhong Li
Sanxin Liu
Qiaoling Wu
Jinwen Feng
Xiaorong Liao
Chunmei Jiang
Bo Liang
Li Yuan
Hai Chen
Jinbo Huang
Zhi Yang
Zhengqi Lu
Hao Li
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-03991-2

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine